Trials / Terminated
TerminatedNCT02081911
Total Knee Arthroplasty Utilizing Adductor Canal Block: Effect on Quadriceps Sparing
Postoperative Pain Management Following Total Knee Arthroplasty Utilizing Adductor Canal Block: Effects on Pain Management and Quadriceps Sparing
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Hospital for Special Surgery, New York · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether there is quantitative motor-sparing of the quadriceps muscles following adductor canal nerve block versus femoral nerve block. Patients will be randomly placed into one of three treatment groups: 1) Femoral nerve block, 2) Adductor canal nerve block - low volume, or 3) Adductor canal nerve block - high volume. Quadriceps function will be assessed in the operating room using a skin patch and electrical stimulation. Follow up visits with the patients will continue over the course of 2 days during patient's stay at the hospital. A total of 60 patients will be enrolled for the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | High Volume Adductor Canal Block | Adductor canal block performed in the distal thigh (1/3 of the total distance between the superior border of the patella and the femoral crease, cephalad to the patella) utilizing an injectate volume of 30 mL 0.25% bupivacaine/ epinephrine |
| PROCEDURE | Low Volume Adductor Canal Block | Adductor canal block performed in the distal thigh (1/3 of the total distance between the superior border of the patella and the femoral crease, cephalad to the patella) utilizing an injectate volume of of 10 mL 0.75% bupivacaine/ epinephrine |
| PROCEDURE | Femoral Nerve Block | Femoral nerve block with 10 mL 0.75 % bupivacaine/epinephrine |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-03-07
- Last updated
- 2016-02-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02081911. Inclusion in this directory is not an endorsement.